|
|
|
|
Wockhardt Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new market report
www.companiesandmarkets.com/Summary-Company-Profile/wockhardt-li ..Wockhardt Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business...
|
|
|
Penile implant infection control strategies vary widely
San DiegoThere is a great deal of variation in infection control strategies among surgeons who implant penile prostheses, prompting the need for detailed guidelines that may be difficult to formulate, two groups reported at the Sexual Medicine Society of North...
|
|
|
Permeability and Concentration of Levofloxacin in Epithelial Lining Fluid in Patients With Lower Respiratory Tract Infections
Zhang J et al.Permeability and Concentration of Levofloxacin in Epithelial Lining Fluid in Patients With Lower Respiratory Tract Infections.
|
|
|
Torrent Pharma gets tentative USFDA nod for Levofloxacin
Drug maker, Torrent Pharmaceuticals has obtained a tentative USFDA nod for Levofloxacin tablet.The said would be available in the tablet form in the strengths of 250 mg, 500 mg, 750 mg respectively. Torrent Pharma gets tentative USFDA nod for ...
|
|
|
Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use
Lee YJ et al.Levofloxacin use was associated with increased resistance of P. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
|
|
|
Antimicrobial susceptibility of multidrug-resistant Streptococcus pneumoniae strains with penicillin MICs of 8
Violeta Rodrguez-Cerrato, a, , , Matilde Graciaa, Gema del Pradoa, Lorena Huelvesa, Plnio Navesa, Vicente Ruiza, Carmen Pontea and Francisco Sorianoa a Department of Medical Microbiology and Antimicrobial Chemotherapy, Fundacin Jimnez Daz-Capio, 28040 Madrid,...
DiagnosticMicrobiology and Infectious Disease:
Feb 14 2010 1:15PM
Matching: levofloxacin
|
Find similar documents
|
|
|
|
5 Days
sidebar My mother-in-law received 5 days of oral levofloxacin (Levaquin) for a urinary tract infection.This was followed by 2 months of C. difficile diarrhea, which was treated with metronidazole (Flagyl) and vancomycin. The diarrhea recurred after...
|
|
|
Wockhardt gets US FDA approval for antibacterial Levofloxacin
Wockhardt has received tentative approval from the US FDA for marketing 250mg, 500mg and 750mg tablets of Levofloxacin, which is used for treatment in a broad spectrum of bacterial infections.Levofloxacin is the generic name for the brand...
|
|
|
Brevundimonas vesicularis keratitis after laser in situ keratomileusis
Pelletier JS et al.The patient remained on topical ceftazidime until improvement was noted and was then switched to topical levofloxacin. The keratitis resolved on antibiotic agents with strong gramnegative coverage and a steroid. Brevundimonas...
|
|
|
Comparative Study of the Mutant Prevention Concentrations of Moxifloxacin, Levofloxacin, and Gemifloxacin against Pneumococci
Credito K et al.The authors tested the propensity of three quinolones to select for resistant Streptococcus pneumoniae mutants by determining the mutant prevention concentration against 100 clinical strains, some of which harbored mutations in type II...
|
|
|
Wockhardt gets US FDA's tentative approval to market Levofloxacin tabs
Pharmaceutical and biotechnology major Wockhardt has received tentative approval from the United States Food & Drug Administration (US FDA) for marketing the 250mg, 500mg and 750mg tablets of Levofloxacin, which is used for treatment in a broad...
|
|
|
Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital
NEW HAVEN, Conn.Under the science plan for the collaboration, Dr. David Hooper 'Treating infections that are resistant to the antibiotics currently available to us has become increasingly challenging,' Dr. Hooper said. 'We are interested to learn more...
|
